Solana Co — Director's Dealing 2018

Jun 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2018-06-25

Reporting Person: ANDREEFF DANE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-25	Class A Common Stock	P	2757	$10.10	Acquired	1488553	Indirect
2018-06-25	Class A Common Stock	P	609	$10.10	Acquired	325947	Indirect
2018-06-25	Class A Common Stock	P	1634	$10.10	Acquired	791069	Indirect
2018-06-26	Class A Common Stock	P	1379	$10.10	Acquired	1489932	Indirect
2018-06-26	Class A Common Stock	P	304	$10.10	Acquired	326251	Indirect
2018-06-26	Class A Common Stock	P	817	$10.10	Acquired	791886	Indirect
2018-06-27	Class A Common Stock	P	1379	$10.11	Acquired	1491311	Indirect
2018-06-27	Class A Common Stock	P	304	$10.11	Acquired	326555	Indirect
2018-06-27	Class A Common Stock	P	817	$10.11	Acquired	792703	Indirect

Footnotes

F1: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F2: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F3: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.